H.C. Wainwright resumed coverage on Artiva Biotherapeutics with a new price target

6/11/25 7:52:47 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

H.C. Wainwright resumed coverage of Artiva Biotherapeutics with a rating of Buy and set a new price target of $12.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ARTV

Date	Price Target	Rating	Analyst
6/11/2025	$12.00	Buy	H.C. Wainwright
12/30/2024	$20.00	Buy	H.C. Wainwright
8/13/2024	$21.00	Buy	Jefferies
8/13/2024	$23.00	Overweight	Cantor Fitzgerald
8/13/2024		Buy	TD Cowen
8/13/2024	$18.00	Outperform	Wedbush
8/13/2024	$23.00	Buy	Needham